References of "Krzesinski, Jean-Marie"
     in
Bookmark and Share    
Full Text
See detailLe Pr J.-M. Krzesinski (CHU sart Tilman, ULg) a sélectionné pour vous...
Krzesinski, Jean-Marie ULg

in Tempo Médical (2002), 240

Detailed reference viewed: 44 (1 ULg)
Full Text
Peer Reviewed
See detailConfirmation des effets délétères rénaux des AINS anti COX2 illustrée par trois cas cliniques
Piront, P.; Krzesinski, Jean-Marie ULg

in Acta Clinica Belgica (2002), 57(1), 35

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailContrôle de l'hypertension artérielle: peut-on faire mieux?
Krzesinski, Jean-Marie ULg

in Journal de Cardiologie [= JDC] = Tijdschrift voor Cardiologie [= TVC] (2002), 14(5), 180-181

Detailed reference viewed: 7 (0 ULg)
Full Text
See detailImplications pour la communauté d'un meilleur contrôle de la pression artérielle
Krzesinski, Jean-Marie ULg

in Journal de Cardiologie [= JDC] = Tijdschrift voor Cardiologie [= TVC] (2002), 14(5), 186-190

Detailed reference viewed: 9 (0 ULg)
Full Text
See detailVers une approche plus efficace du traitement de l'hypertension
Krzesinski, Jean-Marie ULg

in Cardio Spécialistes (2002), 59

Detailed reference viewed: 4 (0 ULg)
Full Text
See detailL'étude MICROHOPE
Krzesinski, Jean-Marie ULg

in Journal de Cardiologie [= JDC] = Tijdschrift voor Cardiologie [= TVC] (2002), 14(5), 170-172

Detailed reference viewed: 15 (0 ULg)
See detailLe rein ischémié
Krzesinski, Jean-Marie ULg

Conference (2001, December 11)

Detailed reference viewed: 18 (0 ULg)
See detailHypertension artérielle et accident vasculaire cérébral
Krzesinski, Jean-Marie ULg

Conference (2001, November 15)

Detailed reference viewed: 28 (8 ULg)
See detailEvidence-Based Medicine
Krzesinski, Jean-Marie ULg

Learning material (2001)

Detailed reference viewed: 13 (4 ULg)
Full Text
Peer Reviewed
See detailEtude clinique du mois. Rôle néphroprotecteur des antagonistes du récepteur de l'angiotensine II (ARA) dans le diabète de type 2: résultats des études IDNT et RENAAL
Weekers, Laurent ULg; Krzesinski, Jean-Marie ULg

in Revue Médicale de Liège (2001), 56(10), 723-726

Nephropathy associated with type 2 diabetes mellitus is a rising cause of end-stage renal disease and is a major public health problem. If blocking of the renin angiotensin system has a well established ... [more ▼]

Nephropathy associated with type 2 diabetes mellitus is a rising cause of end-stage renal disease and is a major public health problem. If blocking of the renin angiotensin system has a well established nephroprotective effect in type 1 diabetic nephropathy, this remained to be shown for type 2 diabetes. Two large outcome trials using angiotensin II receptor antagonists (ARA's) in proteinuric chronic renal impairment and hypertensive type 2 diabetic patients have now closed this gap: the Irbesartan Diabetic Nephropathy Trial (IDNT) and the Reduction of Endpoints in NIDDM with Angiotensin II Antagonist Losartan (RENAAL) trial. Both trials showed a significant reduction in the primary pre-specified end-point of death, or worsening of renal function (doubling of serum creatinine) or the development of end-stage renal disease. This effect goes beyond the reduction in blood pressure and makes of ARA's one of the important tools in the treatment of type 2 diabetic nephropathy. [less ▲]

Detailed reference viewed: 277 (1 ULg)
See detailProtéines alimentaires et fonction rénale
Krzesinski, Jean-Marie ULg

Conference (2001, September 19)

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailLe cas clinique du mois. Syndrome carcinoïde sur tumeur sécrétante du grêle terminal avec cardiopathie
Compere, C.; Geronooz, Isabelle; Croes, F. et al

in Revue Médicale de Liège (2001), 56(9), 599-606

Uncommon but classically described, intestinal carcinoid tumors represent a variety of neuroendocrine tumors. Able to secrete amines and hormones, they can produce characteristic symptoms called ... [more ▼]

Uncommon but classically described, intestinal carcinoid tumors represent a variety of neuroendocrine tumors. Able to secrete amines and hormones, they can produce characteristic symptoms called "carcinoid syndrome". A cardiopathy is sometimes associated with the disease and carries a high risk of mortality and morbidity. [less ▲]

Detailed reference viewed: 347 (7 ULg)
Full Text
Peer Reviewed
See detailComment intégrer l'automesure de la pression artérielle dans la mise au point de l'hypertendu
Krzesinski, Jean-Marie ULg

in Revue Médicale de Liège (2001), 56(8), 552-556

Blood pressure measurement is the cornerstone of the diagnosis and follow up of arterial hypertension. Because of its large variability, the office blood pressure measurement can hardly be trusted. The ... [more ▼]

Blood pressure measurement is the cornerstone of the diagnosis and follow up of arterial hypertension. Because of its large variability, the office blood pressure measurement can hardly be trusted. The blood pressure self measurement allows more precisely to select the hypertensive patients (BP > 135/85 mmHg), to follow with more accuracy patients with important blood pressure variability and to check the efficacy of antihypertensive treatment. The self blood pressure measurement is at the early stage of its scientific period of development but requires the use of strictly validated devices which only measure the blood pressure at the brachial level. [less ▲]

Detailed reference viewed: 198 (0 ULg)
See detailLa dysfonction endothéliale : signification et traitement
Krzesinski, Jean-Marie ULg

Conference (2001, June 20)

Detailed reference viewed: 30 (0 ULg)
See detailL'hypertension artérielle et risque cardio-vasculaire
Krzesinski, Jean-Marie ULg

Conference (2001, May 10)

Detailed reference viewed: 6 (1 ULg)
See detailPlace de l'automesure et hypertension artérielle
Krzesinski, Jean-Marie ULg

Learning material (2001)

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailSport et hypertension artérielle
Krzesinski, Jean-Marie ULg; Ancion, G.

in Revue Médicale de Liège (2001), 56(5), 306-312

Regular physical exercise belongs to the non pharmacological tools for the control of high blood pressure. When practising it almost daily at low intensity during 30 minutes, and mainly on a dynamic mode ... [more ▼]

Regular physical exercise belongs to the non pharmacological tools for the control of high blood pressure. When practising it almost daily at low intensity during 30 minutes, and mainly on a dynamic mode, blood pressure can decrease almost of the same order of magnitude as with an antihypertensive drug. In severe hypertension, blood pressure must be first controlled by drugs before starting the physical exercise training. An exercise test is preferable before exercise suggestion in sedentary people older than 40 years. In hypertensive people who enter sportive competition, diuretics and betablockers are forbidden. These agents can also reduce performance. [less ▲]

Detailed reference viewed: 691 (5 ULg)
Full Text
Peer Reviewed
See detailEffect of candesartan cilexetil and angiotensin-converting enzyme inhibitor therapy on treatment adherence in hypertension
Krzesinski, Jean-Marie ULg; Lins, R.; Vandenhoven, G. et al

in Journal of Hypertension (2001), 19

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailComparison of the candesartan cilexetil and angiotensin-converting enzyme inhibitor therapy in mild to moderate hypertension
Krzesinski, Jean-Marie ULg; Lins, R.; Vandenhoven, G. et al

in Journal of hypertension (2001)

Detailed reference viewed: 9 (0 ULg)